195 related articles for article (PubMed ID: 33817614)
1. An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases.
Bettacchioli E; Le Gaffric C; Mazeas M; Borghi MO; Frostegard J; Barturen G; Makowska Z; Babei S; Lesche R; ; Meroni PL; Alarcon-Riquelme ME; Renaudineau Y
J Transl Autoimmun; 2021; 4():100090. PubMed ID: 33817614
[TBL] [Abstract][Full Text] [Related]
2. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
[TBL] [Abstract][Full Text] [Related]
3. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases.
Marziale A; Bettacchioli E; Picart G; Nafai S; Galinat H; Meroni PL; Frostegard J; ; Alarcon-Riquelme ME; Renaudineau Y
J Autoimmun; 2020 Dec; 115():102524. PubMed ID: 32693965
[TBL] [Abstract][Full Text] [Related]
5. Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome.
van den Hoogen LL; van Roon JAG; Mertens JS; Wienke J; Lopes AP; de Jager W; Rossato M; Pandit A; Wichers CGK; van Wijk F; Fritsch-Stork RDE; Radstake TRDJ
Ann Rheum Dis; 2018 Dec; 77(12):1810-1814. PubMed ID: 30185417
[TBL] [Abstract][Full Text] [Related]
6. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
[TBL] [Abstract][Full Text] [Related]
7. [Serum free light chains for monitoring systemic lupus erythematosus activity].
Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
[TBL] [Abstract][Full Text] [Related]
8. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases.
Thiagarajan D; Oparina N; Lundström S; Zubarev R; Sun J; ; Alarcon-Riquelme M; Frostegård J
Sci Rep; 2020 Jul; 10(1):11010. PubMed ID: 32620913
[TBL] [Abstract][Full Text] [Related]
9. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders.
Szodoray P; Nakken B; Barath S; Csipo I; Nagy G; El-Hage F; Osnes LT; Szegedi G; Bodolay E
Hum Immunol; 2013 Dec; 74(12):1510-8. PubMed ID: 23974054
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases.
Gulli F; Napodano C; Marino M; Ciasca G; Pocino K; Basile V; Visentini M; Stefanile A; Todi L; De Spirito M; Rapaccini GL; Basile U
Clin Exp Immunol; 2020 Feb; 199(2):163-171. PubMed ID: 31618438
[TBL] [Abstract][Full Text] [Related]
11. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
[TBL] [Abstract][Full Text] [Related]
12. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
[TBL] [Abstract][Full Text] [Related]
13. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
[TBL] [Abstract][Full Text] [Related]
14. Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy.
Torell A; Stockfelt M; Blennow K; Zetterberg H; Akhter T; Leonard D; Rönnblom L; Pihl S; Saleh M; Sjöwall C; Strevens H; Jönsen A; Bengtsson AA; Trysberg E; Majczuk Sennström M; Zickert A; Svenungsson E; Gunnarsson I; Bylund J; Jacobsson B; Rudin A; Lundell AC
Arthritis Res Ther; 2024 Mar; 26(1):65. PubMed ID: 38459582
[TBL] [Abstract][Full Text] [Related]
15. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
16. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
[TBL] [Abstract][Full Text] [Related]
18. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
[TBL] [Abstract][Full Text] [Related]
19. Epigenome-Wide Comparative Study Reveals Key Differences Between Mixed Connective Tissue Disease and Related Systemic Autoimmune Diseases.
Carnero-Montoro E; Barturen G; Povedano E; Kerick M; Martinez-Bueno M; ; Ballestar E; Martin J; Teruel M; Alarcón-Riquelme ME
Front Immunol; 2019; 10():1880. PubMed ID: 31440254
[TBL] [Abstract][Full Text] [Related]
20. Determination of serum free light chains as a marker of systemic lupus flare.
Rodríguez-Cambrón AB; Jiménez-Jiménez J; Blázquez-Cañamero MÁ; Pazos FR; Macía-Villa C; Alcalde-Villar M; Collado-Ramos P; Del Pozo FMC; Álvarez-Andrés E; Cruz-Valenciano A
Clin Rheumatol; 2020 Feb; 39(2):449-454. PubMed ID: 31773496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
